Pulmonary delivery of nanomedicines is very promising in lung local disease treatments
whereas several physiological barriers limit its application via the interaction with inhaled …

Particulate matter (PM), which is the primary contributor to air pollution, has become a
pervasive global health threat. When PM enters into a respiratory tract, the first body tissues …

To consider the lung as a target for drug delivery and to optimise strategies directed at the
pulmonary route, it is essential to consider the role of pulmonary surfactant, a thin lipid …

Airborne nanoplastics can be inhaled to threaten human health, but research on the inhaled
nanoplastic toxicity is in its infancy, and interaction mechanisms are largely unknown. By …

Epidemiological studies suggest that environmental factors (eg, air pollution) can influence
the spread and infectivity of coronavirus disease 2019 (COVID-19); however, very few …

Pulmonary drug delivery has drawn great attention due to its targeted local lung action,
reduced side effects, and ease of administration. However, inhaled nanoparticles (NPs) …

Pulmonary surfactant is a membrane-based lipid-protein system essential for the process of
breathing, which coats and stabilizes the whole respiratory surface and possesses …

Exposure of inhaled nanoparticles (NPs) to the deep lung tissue results in the adsorption of
pulmonary surfactant (PSf) on the surface of NPs and the formation of a biomolecular …

The COVID-19 pandemic has wielded an enormous pressure on global health care systems,
economics and politics. Ongoing vaccination campaigns effectively attenuate viral …

Lung surfactant is a complex mixture of lipids and proteins which plays a major role in the
respiratory cycle. This makes necessary to understand the effects of different external factors …